Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.
Who is novosanis
Latest news
March 24 marks World Tuberculosis Day
22/03/2019
24 March marks World Tuberculosis Day, an initiative aimed at spreading knowledge about the epidemic and methods to detect and eliminate the disease. Read our latest blog post about how TB can be detected.
Upcoming event
ECCMID 2019
Amsterdam, NL
We're excited to attend the 29th European Congress of Clinical Microbiology & Infectious Diseases, which will take place in Amsterdam, Netherlands, from 13 - 16 April 2019. Hope to see you there!
Events
Regulatory
Team
News